Loading...
Chimeric Antigen Receptor (CAR)-Engineered Lymphocytes for Cancer Therapy
INTRODUCTION: Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody with the signal activating machinery of a T cell, freeing antigen recognition from major histocompatibility complex restriction and thus breaking one of the barriers to more widespread a...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107373/ https://ncbi.nlm.nih.gov/pubmed/21463133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2011.573476 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|